Sánchez-Prieto R - Search Results

1

ERK5 signalling pathway is a novel target of sorafenib: Implication in EGF biology.

Ortega-Muelas M, Roche O, Fernández-Aroca DM, Encinar JA, Albandea-Rodríguez D, Arconada-Luque E, Pascual-Serra R, Muñoz I, Sánchez-Pérez I, Belandia B, Ruiz-Hidalgo MJ, Sánchez-Prieto R. Ortega-Muelas M, et al. Among authors: sanchez prieto r. J Cell Mol Med. 2021 Nov;25(22):10591-10603. doi: 10.1111/jcmm.16990. Epub 2021 Oct 16. J Cell Mol Med. 2021. PMID: 34655447 Free PMC article.

2

ERK5/BMK1 is a novel target of the tumor suppressor VHL: implication in clear cell renal carcinoma.

Arias-González L, Moreno-Gimeno I, del Campo AR, Serrano-Oviedo L, Valero ML, Esparís-Ogando A, de la Cruz-Morcillo MÁ, Melgar-Rojas P, García-Cano J, Cimas FJ, Hidalgo MJ, Prado A, Callejas-Valera JL, Nam-Cha SH, Giménez-Bachs JM, Salinas-Sánchez AS, Pandiella A, del Peso L, Sánchez-Prieto R. Arias-González L, et al. Neoplasia. 2013 Jun;15(6):649-59. doi: 10.1593/neo.121896. Neoplasia. 2013. PMID: 23730213 Free PMC article.

3

E1a promotes c-Myc-dependent replicative stress: implications in glioblastoma radiosensitization.

Valero ML, Cimas FJ, Arias L, Melgar-Rojas P, García E, Callejas-Valera JL, García-Cano J, Serrano-Oviedo L, de la Cruz-Morcillo MÁ, Sánchez-Pérez I, Sánchez-Prieto R. Valero ML, et al. Cell Cycle. 2014;13(1):52-61. doi: 10.4161/cc.26754. Epub 2013 Oct 11. Cell Cycle. 2014. PMID: 24196438 Free PMC article.

4

Exploiting the potential of autophagy in cisplatin therapy: A new strategy to overcome resistance.

García-Cano J, Ambroise G, Pascual-Serra R, Carrión MC, Serrano-Oviedo L, Ortega-Muelas M, Cimas FJ, Sabater S, Ruiz-Hidalgo MJ, Sanchez Perez I, Mas A, Jalón FA, Vazquez A, Sánchez-Prieto R. García-Cano J, et al. Oncotarget. 2015 Jun 20;6(17):15551-65. doi: 10.18632/oncotarget.3902. Oncotarget. 2015. PMID: 26036632 Free PMC article.

5

DLK1 is a novel inflammatory inhibitor which interferes with NOTCH1 signaling in TLR-activated murine macrophages.

González MJ, Ruiz-García A, Monsalve EM, Sánchez-Prieto R, Laborda J, Díaz-Guerra MJ, Ruiz-Hidalgo MJ. González MJ, et al. Eur J Immunol. 2015 Sep;45(9):2615-27. doi: 10.1002/eji.201545514. Epub 2015 Jul 20. Eur J Immunol. 2015. PMID: 26115479 Free article.

6

MKP1 mediates chemosensitizer effects of E1a in response to cisplatin in non-small cell lung carcinoma cells.

Cimas FJ, Callejas-Valera JL, Pascual-Serra R, García-Cano J, Garcia-Gil E, De la Cruz-Morcillo MA, Ortega-Muelas M, Serrano-Oviedo L, Gutkind JS, Sánchez-Prieto R. Cimas FJ, et al. Oncotarget. 2015 Dec 29;6(42):44095-107. doi: 10.18632/oncotarget.6574. Oncotarget. 2015. PMID: 26689986 Free PMC article.

7

CHK1 expression in Gastric Cancer is modulated by p53 and RB1/E2F1: implications in chemo/radiotherapy response.

Bargiela-Iparraguirre J, Prado-Marchal L, Fernandez-Fuente M, Gutierrez-González A, Moreno-Rubio J, Muñoz-Fernandez M, Sereno M, Sanchez-Prieto R, Perona R, Sanchez-Perez I. Bargiela-Iparraguirre J, et al. Sci Rep. 2016 Feb 12;6:21519. doi: 10.1038/srep21519. Sci Rep. 2016. PMID: 26867682 Free PMC article.

8

p38MAPK and Chemotherapy: We Always Need to Hear Both Sides of the Story.

García-Cano J, Roche O, Cimas FJ, Pascual-Serra R, Ortega-Muelas M, Fernández-Aroca DM, Sánchez-Prieto R. García-Cano J, et al. Front Cell Dev Biol. 2016 Jun 30;4:69. doi: 10.3389/fcell.2016.00069. eCollection 2016. Front Cell Dev Biol. 2016. PMID: 27446920 Free PMC article. Review.

9

KLRC3, a Natural Killer receptor gene, is a key factor involved in glioblastoma tumourigenesis and aggressiveness.

Cheray M, Bessette B, Lacroix A, Mélin C, Jawhari S, Pinet S, Deluche E, Clavère P, Durand K, Sanchez-Prieto R, Jauberteau MO, Battu S, Lalloué F. Cheray M, et al. J Cell Mol Med. 2017 Feb;21(2):244-253. doi: 10.1111/jcmm.12960. Epub 2016 Sep 19. J Cell Mol Med. 2017. PMID: 27641066 Free PMC article.

10

E1a is an exogenous in vivo tumour suppressor.

Cimas FJ, Callejas-Valera JL, García-Olmo DC, Hernández-Losa J, Melgar-Rojas P, Ruiz-Hidalgo MJ, Pascual-Serra R, Ortega-Muelas M, Roche O, Marcos P, Garcia-Gil E, Fernandez-Aroca DM, Ramón Y Cajal S, Gutkind JS, Sanchez-Prieto R. Cimas FJ, et al. Cancer Lett. 2017 Jul 28;399:74-81. doi: 10.1016/j.canlet.2017.04.010. Epub 2017 Apr 15. Cancer Lett. 2017. PMID: 28416454

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

83 results

Search Page